《LANCET,3月13日,COVID-19: consider cytokine storm syndromes and immunosuppression》

  • 来源专题:COVID-19科研动态监测
  • 编译者: xuwenwhlib
  • 发布时间:2020-03-14
  • COVID-19: consider cytokine storm syndromes and immunosuppression

    Published Online March 13, 2020

    https://doi.org/10.1016/S0140-6736(20)30628-0

    As of March 12, 2020, coronavirus disease 2019 (COVID-19) has been confirmed in 125 048 people worldwide, carrying a mortality of approximately 3·7%,1 compared with a mortality rate of less than 1% from influenza. There is an urgent need for effective treatment. Current focus has been on the development of novel therapeutics, including antivirals and vaccines. Accumulating evidence suggests that a subgroup of patients with severe COVID-19 might

    have a cytokine storm syndrome. We recommend identification and treatment of hyperinflammation using existing, approved therapies with proven safety profiles to address the immediate need to reduce the rising mortality.

  • 原文来源:https://www.thelancet.com/lancet/article/S0140-6736(20)30628-0
相关报告
  • 《LANCET,3月13日,COVID-19: delay, mitigate, and communicate》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-03-14
    • COVID-19: delay, mitigate, and communicate Published Online March 13, 2020 https://doi.org/10.1016/S2213-2600(20)30128-4 On March 11, 2020, WHO declared COVID-19 a pandemicand has called for governments to take “urgent and aggressive action” to change the course of the outbreak. As of March 12, 2020, the USA has suspended all travel from 26 European countries, and Italy is the latest country to enforce widespread lockdown measures to curb the spread of the virus. Robust plans and policies to avoid the disease trajectories seen in the worst-hit countries are urgentlyneeded. These responses must be proportionate to each country’s situation and communicated in a clear and balanced way to avoid spreading fear and panic.
  • 《LANCET,3月23日,COVID-19 and medical education》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-24
    • COVID-19 and medical education Hanad Ahmed Mohammed Allaf Hussein Elghazaly Published:March 23, 2020DOI:https://doi.org/10.1016/S1473-3099(20)30226-7 The coronavirus disease 2019 (COVID-19) outbreak has rapidly transitioned into a worldwide pandemic. This development has had serious implications for public institutions and raises particular questions for medical schools. Frequent rotations between departments and hospitals make medical students potential vectors for COVID-19. Equally, as trainee doctors we stand to learn a tremendous amount and can contribute to the care of patients, particularly if the UK General Medical Council triggers article 18a of the Medical Student Act (1983).